Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Depreciation & Amortization (CF) (2024 - 2025)

Profound Medical has reported Depreciation & Amortization (CF) over the past 2 years, most recently at $62000.0 for Q4 2025.

  • Quarterly results put Depreciation & Amortization (CF) at $62000.0 for Q4 2025, down 61.25% from a year ago — trailing twelve months through Dec 2025 was $373000.0 (down 47.24% YoY), and the annual figure for FY2025 was $373000.0, down 47.24%.
  • Depreciation & Amortization (CF) for Q4 2025 was $62000.0 at Profound Medical, down from $93000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for PROF hit a ceiling of $199000.0 in Q1 2024 and a floor of $62000.0 in Q4 2025.